The University of Minnesota has begun a clinical study to test whether a novel cell therapy currently under clinical investigation as a treatment for acute myeloid leukemia and lymphoma can be effective as a treatment for COVID-19.
Leadership is changing at The Wistar Institute and the Helen F. Graham Cancer Center & Research Institute in the months to come—but the leaders of the two institutions say that this will have little if any effect on the clinical-research collaboration that they have spent the past 15years building (The Cancer Letter, July 12, 2019).
